Genomic Health
Curated by SignalGenomic-based diagnostic tests for cancer
Overview
Genomic-based diagnostic tests for cancer. The company uses algorithms to analyze gene expression data and to arrive at a prognosis score for different types of cancer. Its flagship product is the OncotypeDx for Breast cancer that provides a risk of recurrence in breast cancer patients suffering post-surgery. In addition, Genomic Health also has OncotypeDx tests for prostate cancer and colon cancer.
Key facts
- Founded
- 2000
- Headquarters
- Redwood City, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology